LLY

912.56

+0.99%↑

JNJ

240.05

+2.01%↑

ABBV

206.33

+0.73%↑

NVS

150.79

+1.38%↑

MRK

118.86

+2.37%↑

LLY

912.56

+0.99%↑

JNJ

240.05

+2.01%↑

ABBV

206.33

+0.73%↑

NVS

150.79

+1.38%↑

MRK

118.86

+2.37%↑

LLY

912.56

+0.99%↑

JNJ

240.05

+2.01%↑

ABBV

206.33

+0.73%↑

NVS

150.79

+1.38%↑

MRK

118.86

+2.37%↑

LLY

912.56

+0.99%↑

JNJ

240.05

+2.01%↑

ABBV

206.33

+0.73%↑

NVS

150.79

+1.38%↑

MRK

118.86

+2.37%↑

LLY

912.56

+0.99%↑

JNJ

240.05

+2.01%↑

ABBV

206.33

+0.73%↑

NVS

150.79

+1.38%↑

MRK

118.86

+2.37%↑

Search

Bausch Health Cos Inc

Aperta

SettoreSettore sanitario

5.07 1.6

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

4.99

Massimo

5.21

Metriche Chiave

By Trading Economics

Entrata

-295M

-114M

Vendite

158M

2.8B

P/E

Media del settore

12.143

57.05

Margine di Profitto

-4.006

Dipendenti

20,300

EBITDA

-277M

659M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+42.16% upside

Dividendi

By Dow Jones

Utili prossimi

29 apr 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-329M

1.9B

Apertura precedente

3.47

Chiusura precedente

5.07

Notizie sul Sentiment di mercato

By Acuity

54%

46%

295 / 350 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bearish Evidence

Bausch Health Cos Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

22 apr 2025, 13:12 UTC

Acquisizioni, Fusioni, Takeovers

Bausch Health Learns Icahn Has 34% Economic Interest in Shares

Confronto tra pari

Modifica del prezzo

Bausch Health Cos Inc Previsione

Obiettivo di Prezzo

By TipRanks

42.16% in crescita

Previsioni per 12 mesi

Media 7.25 USD  42.16%

Alto 10 USD

Basso 5 USD

Basato su 5 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Bausch Health Cos Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

5 ratings

0

Acquista

4

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

4.63 / 5.35Supporto e resistenza

A breve termine

Strong Bearish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

295 / 350 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove ribassiste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Bausch Health Cos Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
help-icon Live chat